14527-46-9,MFCD08436042
Catalog No.:AA001KNN

14527-46-9 | 5-Nitrothiazole

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
≥ 95% (HPLC)
in stock  
$132.00   $93.00
- +
1g
98%
in stock  
$140.00   $98.00
- +
5g
98%
in stock  
$454.00   $318.00
- +
10g
98%
in stock  
$894.00   $626.00
- +
25g
98%
in stock  
$2,020.00 $1,414.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA001KNN
Chemical Name:
5-Nitrothiazole
CAS Number:
14527-46-9
Molecular Formula:
C3H2N2O2S
Molecular Weight:
130.1252
MDL Number:
MFCD08436042
SMILES:
[O-][N+](=O)c1cncs1
Properties
Properties
 
BP:
250.5°C at 760 mmHg  
Form:
Solid  
MP:
55-57 °C  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
102  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
8  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
0  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.1  

Downstream Synthesis Route

[1]HelveticaChimicaActa,1955,vol.38,p.1412

[1]Strehlke[ChemischeBerichte,1973,vol.106,#2,p.721-722]

14527-46-9    28868-76-0   
2-(5-Nitro-thiazol-2-yl)-malonicaciddimethylester 

[1]PolishJournalofChemistry,1995,vol.69,p.918-921

Literature

Title: Development of 5-nitrothiazole derivatives: identification of leads against both replicative and latent Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20121215

Title: Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.

Journal: Parasitology research 20100901

Title: 5-Nitrothiazolylthiosemicarbazones: synthesis and antimycobacterial evaluation against tubercular and non-tubercular mycobacterial species.

Journal: Journal of enzyme inhibition and medicinal chemistry 20100201

Title: Synthesis of new potentially bioactive bicyclic 2-pyridones.

Journal: Molecules (Basel, Switzerland) 20051031

Title: In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites.

Journal: The Journal of eukaryotic microbiology 20020101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 14527-46-9
Tags:14527-46-9 Molecular Formula|14527-46-9 MDL|14527-46-9 SMILES|14527-46-9 5-Nitrothiazole
Catalog No.: AA001KNN
14527-46-9,MFCD08436042
14527-46-9 | 5-Nitrothiazole
Pack Size: 250mg
Purity: ≥ 95% (HPLC)
in stock
$132.00 $93.00
Pack Size: 1g
Purity: 98%
in stock
$140.00 $98.00
Pack Size: 5g
Purity: 98%
in stock
$454.00 $318.00
Pack Size: 10g
Purity: 98%
in stock
$894.00 $626.00
Pack Size: 25g
Purity: 98%
in stock
$2,020.00 $1,414.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA001KNN
Chemical Name: 5-Nitrothiazole
CAS Number: 14527-46-9
Molecular Formula: C3H2N2O2S
Molecular Weight: 130.1252
MDL Number: MFCD08436042
SMILES: [O-][N+](=O)c1cncs1
Properties
BP: 250.5°C at 760 mmHg  
Form: Solid  
MP: 55-57 °C  
Storage: Keep in dry area;2-8℃;  
Complexity: 102  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 8  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 0  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.1  
Downstream Synthesis Route
3034-48-8    14527-46-9 

[1]HelveticaChimicaActa,1955,vol.38,p.1412

39920-61-1    14527-46-9 

[1]Strehlke[ChemischeBerichte,1973,vol.106,#2,p.721-722]

14527-46-9    28868-76-0   
2-(5-Nitro-thiazol-2-yl)-malonicaciddimethylester 

[1]PolishJournalofChemistry,1995,vol.69,p.918-921

Literature fold

Title: Development of 5-nitrothiazole derivatives: identification of leads against both replicative and latent Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20121215

Title: Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.

Journal: Parasitology research20100901

Title: 5-Nitrothiazolylthiosemicarbazones: synthesis and antimycobacterial evaluation against tubercular and non-tubercular mycobacterial species.

Journal: Journal of enzyme inhibition and medicinal chemistry20100201

Title: Synthesis of new potentially bioactive bicyclic 2-pyridones.

Journal: Molecules (Basel, Switzerland)20051031

Title: In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites.

Journal: The Journal of eukaryotic microbiology20020101

Building Blocks More >
148546-97-8
148546-97-8
1-Methyl-4-(3-nitrophenyl)piperazine
AA001KWW | MFCD08435858
14898-67-0
14898-67-0
Ruthenium(III) chloride hydrate(1:x)
AA001L8X | MFCD18909709
149353-73-1
149353-73-1
3-(tert-Butoxycarbonyl)-2,3,4,5-tetrahydro-1h-benzo[d]azepine-7-carboxylic acid
AA001LJM | MFCD09264010
149669-45-4
149669-45-4
6-Methyl-3-(piperidin-4-yl)-1h-indole
AA001LU9 | MFCD04114997
150-60-7
150-60-7
Dibenzyl disulfide
AA001M4I | MFCD00004783
15029-36-4
15029-36-4
2-Cyano-n-ethylacetamide
AA001MEO | MFCD00118415
150630-13-0
150630-13-0
3-Benzyloxy-2-methyl-pyridin-4-ol
AA001MPF | MFCD02180546
151104-75-5
151104-75-5
3-Amino-5-(methylsulfonyl)benzoic acid
AA001N12 | MFCD16059721
151541-15-0
151541-15-0
Ethyl 3-(4-(benzyloxy)-3,5-dimethoxyphenyl)-3-hydroxy-2-(2-methoxyphenoxy)propanoate
AA001NC0 | MFCD28399423
155172-12-6
155172-12-6
Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, 2-oxide
AA001NMD | MFCD18252394
Submit
© 2017 AA BLOCKS, INC. All rights reserved.